276 related articles for article (PubMed ID: 23030323)
1. Viral latency and potential eradication of HIV-1.
Matreyek KA; Oztop I; Freed EO; Engelman A
Expert Rev Anti Infect Ther; 2012 Aug; 10(8):855-7. PubMed ID: 23030323
[TBL] [Abstract][Full Text] [Related]
2. Stimulating the RIG-I pathway to kill cells in the latent HIV reservoir following viral reactivation.
Li P; Kaiser P; Lampiris HW; Kim P; Yukl SA; Havlir DV; Greene WC; Wong JK
Nat Med; 2016 Jul; 22(7):807-11. PubMed ID: 27294875
[TBL] [Abstract][Full Text] [Related]
3. Stimulation of HIV-1-specific cytolytic T lymphocytes facilitates elimination of latent viral reservoir after virus reactivation.
Shan L; Deng K; Shroff NS; Durand CM; Rabi SA; Yang HC; Zhang H; Margolick JB; Blankson JN; Siliciano RF
Immunity; 2012 Mar; 36(3):491-501. PubMed ID: 22406268
[TBL] [Abstract][Full Text] [Related]
4. Targeting the Latent Reservoir for HIV-1.
Sengupta S; Siliciano RF
Immunity; 2018 May; 48(5):872-895. PubMed ID: 29768175
[TBL] [Abstract][Full Text] [Related]
5. Reservoirs for HIV-1: mechanisms for viral persistence in the presence of antiviral immune responses and antiretroviral therapy.
Pierson T; McArthur J; Siliciano RF
Annu Rev Immunol; 2000; 18():665-708. PubMed ID: 10837072
[TBL] [Abstract][Full Text] [Related]
6. Short Communication: The Broad-Spectrum Histone Deacetylase Inhibitors Vorinostat and Panobinostat Activate Latent HIV in CD4(+) T Cells In Part Through Phosphorylation of the T-Loop of the CDK9 Subunit of P-TEFb.
Jamaluddin MS; Hu PW; Jan Y; Siwak EB; Rice AP
AIDS Res Hum Retroviruses; 2016 Feb; 32(2):169-73. PubMed ID: 26727990
[TBL] [Abstract][Full Text] [Related]
7. HAART-persistent HIV-1 latent reservoirs: their origin, mechanisms of stability and potential strategies for eradication.
Kulkosky J; Bray S
Curr HIV Res; 2006 Apr; 4(2):199-208. PubMed ID: 16611058
[TBL] [Abstract][Full Text] [Related]
8. Advancements in Developing Strategies for Sterilizing and Functional HIV Cures.
Xu W; Li H; Wang Q; Hua C; Zhang H; Li W; Jiang S; Lu L
Biomed Res Int; 2017; 2017():6096134. PubMed ID: 28529952
[TBL] [Abstract][Full Text] [Related]
9. Low Inducibility of Latent Human Immunodeficiency Virus Type 1 Proviruses as a Major Barrier to Cure.
Siliciano JD; Siliciano RF
J Infect Dis; 2021 Feb; 223(12 Suppl 2):13-21. PubMed ID: 33586775
[TBL] [Abstract][Full Text] [Related]
10. From reactivation of latent HIV-1 to elimination of the latent reservoir: the presence of multiple barriers to viral eradication.
Shan L; Siliciano RF
Bioessays; 2013 Jun; 35(6):544-52. PubMed ID: 23613347
[TBL] [Abstract][Full Text] [Related]
11. Innate Immune Activity Correlates with CD4 T Cell-Associated HIV-1 DNA Decline during Latency-Reversing Treatment with Panobinostat.
Olesen R; Vigano S; Rasmussen TA; Søgaard OS; Ouyang Z; Buzon M; Bashirova A; Carrington M; Palmer S; Brinkmann CR; Yu XG; Østergaard L; Tolstrup M; Lichterfeld M
J Virol; 2015 Oct; 89(20):10176-89. PubMed ID: 26223643
[TBL] [Abstract][Full Text] [Related]
12. Bryostatin-1 synergizes with histone deacetylase inhibitors to reactivate HIV-1 from latency.
Pérez M; de Vinuesa AG; Sanchez-Duffhues G; Marquez N; Bellido ML; Muñoz-Fernandez MA; Moreno S; Castor TP; Calzado MA; Muñoz E
Curr HIV Res; 2010 Sep; 8(6):418-29. PubMed ID: 20636281
[TBL] [Abstract][Full Text] [Related]
13. A stable latent reservoir for HIV-1 in resting CD4(+) T lymphocytes in infected children.
Persaud D; Pierson T; Ruff C; Finzi D; Chadwick KR; Margolick JB; Ruff A; Hutton N; Ray S; Siliciano RF
J Clin Invest; 2000 Apr; 105(7):995-1003. PubMed ID: 10749578
[TBL] [Abstract][Full Text] [Related]
14. Reservoirs, sanctuaries, and residual disease: the hiding spots of HIV-1.
Pomerantz RJ
HIV Clin Trials; 2003; 4(2):137-43. PubMed ID: 12671782
[TBL] [Abstract][Full Text] [Related]
15. Measuring replication competent HIV-1: advances and challenges in defining the latent reservoir.
Wang Z; Simonetti FR; Siliciano RF; Laird GM
Retrovirology; 2018 Feb; 15(1):21. PubMed ID: 29433524
[TBL] [Abstract][Full Text] [Related]
16. Low-level HIV-1 replication and the dynamics of the resting CD4+ T cell reservoir for HIV-1 in the setting of HAART.
Sedaghat AR; Siliciano RF; Wilke CO
BMC Infect Dis; 2008 Jan; 8():2. PubMed ID: 18171475
[TBL] [Abstract][Full Text] [Related]
17. Limits on replenishment of the resting CD4+ T cell reservoir for HIV in patients on HAART.
Sedaghat AR; Siliciano JD; Brennan TP; Wilke CO; Siliciano RF
PLoS Pathog; 2007 Aug; 3(8):e122. PubMed ID: 17784786
[TBL] [Abstract][Full Text] [Related]
18. Autologous neutralizing antibody to human immunodeficiency virus-1 and replication-competent virus recovered from CD4+ T-cell reservoirs in pediatric HIV-1-infected patients on HAART.
Ching N; Nielsen-Saines KA; Deville JG; Wei LS; Garratty E; Bryson YJ
AIDS Res Hum Retroviruses; 2010 May; 26(5):585-91. PubMed ID: 20455762
[TBL] [Abstract][Full Text] [Related]
19. The forces driving clonal expansion of the HIV-1 latent reservoir.
Liu R; Simonetti FR; Ho YC
Virol J; 2020 Jan; 17(1):4. PubMed ID: 31910871
[TBL] [Abstract][Full Text] [Related]
20. Viral reservoirs, residual viremia, and the potential of highly active antiretroviral therapy to eradicate HIV infection.
Shen L; Siliciano RF
J Allergy Clin Immunol; 2008 Jul; 122(1):22-8. PubMed ID: 18602567
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
